Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
81 results about "Chronic failure" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Medicines composition for treating chronic heart failure and its prepn
InactiveCN1403149AImprove urine outputProlong cold swimming timeUnknown materialsCardiovascular disorderRhizomeAstragalus mongholicus
The present invention provides one composite medicine for treating chronic heart failure. The composite medicine has the functions of invigorating vital energy, dredging meridian, promoting blood circulation and diuresis. The medicine composition has 11 kinds of Chinese medicinal materials including astragalus root or white atractylodes rhizome, mankshood, ginseng or Dangshen, red sage, pepperweed seed, etc. The pharmacological test shows that the capsule of the present invention has obvious improving effects to heart failure of dog caused by Pentobarbital sodium.
Owner:SHIJIAZHUANG YILING PHARMA
Systems and methods for treating acute and chronic heart failure
ActiveUS9393384B1Reduce riskImprove the quality of lifeElectrocardiographyBalloon catheterVeinCardiac cycle
Systems and methods and devices are provided for arresting or reversing the effects of myocardial remodeling and degeneration after cardiac injury, without the potential drawbacks associated with previously existing systems and methods, by at least partially occluding flow through the superior vena cava over multiple cardiac cycles, and more preferably, by adjusting the interval or degree of occlusion responsive to a sensed level of patient activity. In some embodiments, a controller is provided that actuates a drive mechanism responsive to a sensed level of patient activity to provide at least partial occlusion of the patient's superior vena cava, while a data transfer circuit of the controller provides bi-directional transfer of physiologic data to the patient's smartphone or tablet to permit display and review of such data.
Owner:TUFTS MEDICAL CENTER INC
Chinese medicine for treating chronic renal failure
InactiveCN101502619APromote absorptionAvoid absorptionMammal material medical ingredientsUrinary disorderLife qualityPinellia
The invention discloses a traditional Chinese medicine for treating chronic renal failure and aims at solving the problems that the prior art supports the life by dialysis so as to result in short life cycle of patients and high cost and the like. The traditional Chinese medicine comprises the following raw materials: 30g of raidx astragali, 10g of white ginseng, 20g of rhizoma atractylodis macrocephalae, 20g of honey-fried licorice root, 20g of poria, 10g of Chinese angelica, 20g of rehmannia glutinosa, 20g of white paeony root, 10g of wrinkled gianthyssop herb, 15g of pinellia tuber and the like. The prescription is used for treating chronic uremia, can invigorate vigour, strengthening the spleen, replenishing blood, nourishing the blood, excreting water, expel toxin, strengthening the kidney and expel toxin, can reduce dialysis gradually by combining the modern medical method, finally separate the dialysis and transfusion, relieve economic burden of the patients, improve disease process fundamentally, improve life quality and courage and prolong life cycle.
Owner:刘云
Therapeutic agent for chronic renal failure
ActiveUS20110178103A1Suppression of decrease in renal functionRecovery functionOrganic active ingredientsOrganic chemistryUremiaBiological activation
The present invention aims to provide a therapeutic agent for chronic renal failure, comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof. That is, the present invention provides provision of a drug comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof, which drug is useful not only for amelioration of renal function, but also for amelioration of anemia, activation of SOD and excretion of uremic substances.
Owner:TORAY IND INC
System for treating acute and chronic heart failure
ActiveUS20180243541A1Reduce riskImprove the quality of lifeElectrocardiographyBalloon catheterVeinCardiac cycle
Systems and methods and devices are provided for arresting or reversing the effects of myocardial remodeling and degeneration after cardiac injury, without the potential drawbacks associated with previously existing systems and methods, by at least partially occluding flow through the superior vena cava over multiple cardiac cycles, and more preferably, by adjusting the interval or degree of occlusion responsive to a sensed level of patient activity. In some embodiments, a controller is provided that actuates a drive mechanism responsive to a sensed level of patient activity to provide at least partial occlusion of the patient's superior vena cava, while a data transfer circuit of the controller provides bi-directional transfer of physiologic data to the patient's smartphone or tablet to permit display and review of such data.
Owner:TUFTS MEDICAL CENTER INC
Traditional Chinese medicine for treating chronic renal failure
InactiveCN104984124ASafe and effective treatmentComparableAnthropod material medical ingredientsUrinary disorderMedicinal herbsPinellia
The invention relates to a traditional Chinese medicine for treating chronic renal failure. The traditional Chinese medicine is prepared from the following raw medicinal materials in parts by weight: 30 parts of asiatic centella, 10 parts of caulis bambusae in taenian, 30 parts of astragali radix, 12 parts of dodder, 25 parts of serissa serissoide, 15 parts of silkworm excrement, 15 parts of Dangshen and 9 parts of tuber pinellia. Clinic experiments prove that the traditional Chinese medicine can be used for safely and effectively treating the chronic renal failure.
Owner:吴斌
Medicines composition for treating chronic heart failure and its prepn
InactiveCN1186071CImprove urine outputProlong cold swimming timeUnknown materialsCardiovascular disorderRhizomeAstragalus mongholicus
The present invention provides one composite medicine for treating chronic heart failure. The composite medicine has the functions of invigorating vital energy, dredging meridian, promoting blood circulation and diuresis. The medicine composition has 11 kinds of Chinese medicinal materials including astragalus root or white atractylodes rhizome, mankshood, ginseng or Dangshen, red sage, pepperweed seed, etc. The pharmacological test shows that the capsule of the present invention has obvious improving effects to heart failure of dog caused by Pentobarbital sodium.
Owner:SHIJIAZHUANG YILING PHARMA
Medicament for treating chronic renal failure and production method
ActiveCN101347454ANo change in dispersionNo side effectsPowder deliverySolution deliveryHemodialysisSide effect
The invention relates to a medicine for curing chronic renal failure and a production method thereof, which is characterized in that the medicine is calcium-base samoite excluding K+, Na+, Mg2+ and other exchangeable cations. The preparation method includes immersing the samoite in calcium chloride solution and then exchanging ions. After oral administration, toxins in the alimentary tract of patients with chronic renal failure is absorbed by samoite of the medicine and then discharged out of the body along with intestinal peristalsis, thus achieving intestinal hemodialysis. While absorbing and fixing the toxins in the alimentary tract, the calcium-base samoite has no side effect on patients of Na and K restriction without releasing K+, Na+, Mg2+ and other exchangeable cations.
Owner:SHANDONG TIANSHUN PHARMA
Chinese medicinal formula for treating chronic renal failure
InactiveCN102579755APromote excretionPromote recoveryUrinary disorderPlant ingredientsSalvia miltiorrhizaErica umbellata
The invention relates to a Chinese medicinal formula for treating chronic renal failure. The formula consists of the following raw materials by weight (counted by gram): 12-16g of roasted aconite (decocted firstly), 12-16g of south dodder seed, 15-22g of cortex eucommiae, 15-22g of astragalus, 15-22g of dangshen, 15-22g of indian buead, 12-18g of large-head atractylodes rhizome, 15-22g of Chinese yam, 12-18g of pokeberry root, 12-16g of areca peel, 15-22g of umbellate pore fungus, 20-30g of rhubarb, 25-32g of red-rooted salvia root, 25-32g of honeysuckle flower, 25-32g of dandelion and 15-22g of sweet basil. After being taken by a patient suffering from chronic renal failure, a medicament prepared in the weight ratio has the effects of exciting potential, improving physique, improving symptoms, promoting the excretion of metabolic waste, relieving the state of an illness and prolonging life.
Owner:ZUNYI NO 1 PEOPLES HOSPITAL
Therapies for chronic renal failure
InactiveUS7524817B2Preventing delaying needReduce frequencyOrganic active ingredientsPeptide/protein ingredientsChronic kidney failureOsteogenic proteins
Owner:MARIEL THERAPEUTICS
Preparation method of chronic renal failure colon dialysate
InactiveCN103301355AReduce usageImprove permeabilityBlood disorderExtracellular fluid disorderTrikeraia hookeriGastrodia
The invention discloses a preparation method of a chronic renal failure colon dialysate for solving the treatment problem of chronic renal failure. The preparation method is characterized in that the preparation method comprises the following steps of: (1) performing reduced pressure distillation on ailanthus-like pricklyash bark, catclaw buttercup root and Chinese ephedra root coarse powder to extract volatile oil; (2) performing reduced pressure decoction on tall gastrodia tuber to obtain a filtrate; (3) performing water decoction on trikeraia hookeri, magnolia amoena, dragon's blood, melanoidin malt, scorch-fried medicated leaven, mimoselike rosewood leaf, peach gum, cassia twig and dregs obtained in the step (1) to obtain a filtrate for later use; (4) merging the filtrates obtained in the steps (2) and (3), performing reduced pressure concentration to obtain a dry extract, and crushing to obtain dry extract powder; (5) spraying the volatile oil obtained in the step (1) into the dry extract powder obtained in the step (4), uniformly mixing, and screening by a 100-mesh screen to obtain colon dialysis concentrated powder; and (6) adding ten times the volume of warm water into the colon dialysis concentrated powder obtained in the step (5) during the use, and uniformly mixing. Clinical experiments prove that by using the chronic renal failure colon dialysate for treating the chronic renal failure, the frequency of hemodialysis can be reduced, and the preparation method is further worthy of clinical application and popularization.
Owner:都雯静
Traditional Chinese medicine special for treating diabetic nephropathy with chronic renal failure
ActiveCN104547333AReduce intakeImprove glucose and lipid metabolism disordersMetabolism disorderUrinary disorderCurative effectTherapeutic effect
The invention provides a traditional Chinese medicine special for treating diabetic nephropathy with chronic renal failure. The traditional Chinese medicine is prepared from the following components in parts by weight: 10 to 12% of rheum officinale, 20 to 25% of astragalus membranaceus, 10 to 12% of wine-prepared fructus corni, 10 to 12% of prepared rehmannia root, 20 to 25% of poria cocos, and 15 to 20% of rhizoma alismatis. The traditional Chinese medicine can be used for effectively and safely delaying kidney failure and glucose and lipid metabolism disorder and comprehensively treating diabetes renal complications, has an obvious treatment effect, and is low in cost.
Owner:南京鼓楼医院集团安庆市石化医院有限公司 +1
Wireless data service equipment self-diagnosis method and system
InactiveCN101696999APreventing Malfunctions from DevelopingEnsure safetyElectrical testingThermometerWireless data servicesTerminal equipment
The invention relates to data service equipment technology, and discloses a wireless data service equipment self-diagnosis method and a wireless data service equipment self-diagnosis system. The method comprises: acquiring effective values of working parameters of DC-DC in a low power consumption working mode in the equipment; and if the different between the effective values and normal parameter values is greater than a preset threshold, determining that the equipment has a fault. The method can prevent malign development of the fault of the high heat flux data service terminal equipment caused by DC-DC chronic failure, and ensures the use safety of the data service terminal equipment.
Owner:HUAWEI DEVICE (SHENZHEN) CO LTD
Drug composition for treating chronic heart failure
InactiveCN103169855AImprove clinical symptomsSigns improvedCardiovascular disorderPlant ingredientsMonkshoodsRadix Ophiopogonis
The invention relates to a drug composition for treating chronic heart failure. The drug composition is prepared from the crude drugs of traditional Chinese medicines such as ginseng, monkshood (fried), astragalus mongholicus, radix ophiopogonis, root of red-rooted salvia, rhizoma alismatis, tuckahoe, plantain herb and the like. The drug composition has the effects of warming yang and reinforcing qi, promoting blood circulation and excreting pathogenic water, and is clinically used for treating the chronic heart failure.
Owner:谭建
Therapeutic agent for chronic renal failure
ActiveUS8575175B2Reduce functionRecovery functionOrganic active ingredientsOrganic chemistryUremiaBiological activation
The present invention aims to provide a therapeutic agent for chronic renal failure, comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof. That is, the present invention provides provision of a drug comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof, which drug is useful not only for amelioration of renal function, but also for amelioration of anemia, activation of SOD and excretion of uremic substances.
Owner:TORAY IND INC
Cardiotonic capsule for treating chronic heart failure
InactiveCN103142845ASymptoms improvedPromote remodelingCardiovascular disorderLeech/worm material medical ingredientsMonkshoodsSide effect
The invention discloses a cardiotonic capsule for treating chronic heart failure and belongs to the field of traditional Chinese medicines. A preparation method of the cardiotonic capsule comprises the following steps of mixing 3-5 parts by mass of milkvetch root, 3-5 parts by mass of red ginseng, 3-5 parts by mass of prepared monkshood, 2-10 parts by mass of semen lepidii, 3-5 parts by mass of radix ophiopogonis, 2-3 parts by mass of Chinese magnoliavine fruit, 2-3 parts by mass of polygonatum odoratum, 3-5 parts by mass of radix salviae miltiorrhizae, 2-3 parts by mass of ligusticum wallichii, 3-5 parts by mass of kudzuvine root powder, 3-5 parts by mass of radix notoginseng and 3-5 parts by mass of leech, crushing the mixture into fine powder, and filling the fine powder into capsules. The cardiotonic capsule for treating chronic heart failure does not produce any toxic and side effect, is not limited by contraindication, has good effects of treating chronic constrictive and diastolic heart failure, is especially suitable for diastolic heart failure, can improve heart failure symptoms, can correct heart failure pathological and physiological changes, can reverse atherosclerosis, and can improve ischemic myocardial injuries, cardiac muscle and blood vessel remodeling and long-term prognosis of heart failure patients.
Owner:周长勤
Kidney-health patch for treating chronic renal failure and preparation method thereof
ActiveCN102475753AIncrease inputImprove the ratio effectUrinary disorderSheet deliverySide effectKidney
The invention relates to a kidney-health patch for treating chronic renal failure and a preparation method thereof, and the kidney-health patch is prepared by the following raw material herbs: 1500 g of rheum officinale, 1500 g of salvia, 4500 g of radix astragali, 1500 g of safflower. The preparation method comprises the following steps: extracting raw material herbs of rheum officinale and salvia according to the formula ratios, performing first alcohol precipitation, tannin removal, second alcohol precipitation, water precipitation, third alcohol precipitation, and second water precipitation; extracting radix astragali and safflower according to the formula ratios, performing first alcohol precipitation, water precipitation, second alcohol precipitation, water precipitation, concentration, and drying to prepare the patch. The advantages of the invention are that accurate adjustment is performed based on the original ratios; the patch has less side effect, is safe for application, has lasting effect and high bioavailability.
Owner:XIAN SHIJISHENGKANG PHARMA IND
Chinese medicinal kidney healing powder for treating chronic renal failure
InactiveCN102526614ASlow down the progression of kidney failureImprove clinical symptomsPowder deliveryUrinary disorderSide effectCreatinine rise
The invention discloses an external powder for treating chronic renal failure. The external powder is powder prepared from epimedium herb, south dodder seed, astragalus, cortex eucommiae, turmeric root-tuber, Chinese angelica, red-rooted salvia root, medicinal indianmulberry root, liquoric root, costus root, white pepper and borneol, is blended into paste by using rice wine, and is externally applied to an umbilical region. Due to the adoption of the external powder, the serum creatinine and urea nitrogen of a patient can be reduced effectively, the renal failure process is delayed, and the clinical symptom is improved; and as proved by clinical test, the total effective rate is 88.8 percent, the side effect is small, severe untoward effects are avoided, and a treatment method is simple.
Owner:王遐
Use of sea collagen peptides in preparing medicine or food for protecting kidney function, delaying chronic renal failure
InactiveCN101390880AProtective functionDelayed usePeptide/protein ingredientsUrinary disorderSolubilityOligopeptide
The invention relates to a marine collagen peptide and the application thereof in the preparation of medicine, health food or food used for the protection of renal function and slowing the progress of chronic renal failure. Marine collagen peptide is a group of low-molecular weight oligopeptide mixture generated through the hydrolysis of fish skins of marine fish (salmon, chinook salmon, tilapia and the like). The molecular weight of 70%-80% of oligopeptide is distributed between 200-1000Da. The marine collagen peptide has the advantages of easy absorption, fast absorption, low viscosity, good water-solubility. The experiments prove that the marine collagen peptide can have the efficacy of slowing the adenine-induced chronic renal function impairment of rats.
Owner:珍奥集团股份有限公司 +2
Clysis liquid used for chronic renal failure
ActiveCN103341095AReduce usageImprove permeabilityUrinary disorderPlant ingredientsCurative effectPrunus
The invention discloses a clysis liquid used for chronic renal failure, solving the problem of the treatment of chronic renal failure. The clysis liquid is prepared from the following raw medicines: erythrina indica lam, trikeraia hookeri, tetrapanax papyriferum, magnolia amoena, sangusis draconis, radix ranunculi ternate, caramel malt, medicated leaven, mussel, folium dalbergiae mimosoidis, prunus persica (L.) batsch and cassia twig. The clinical experiment result shows that the clysis liquid has the characteristics of high curative effect and relatively high safety on chronic renal failure treatment, and is worthy for clinical application and popularization.
Owner:中芝堂药业(山东)有限公司
Traditional Chinese medicine combination for treating chronic renal failure
InactiveCN106166262AStrict compatibilityDialectical legislationDispersion deliveryUrinary disorderCreatinine riseAzotemia
Owner:邓炳章
Early warning system for chronic renal failure
InactiveCN106361289ATimely detection of non-obvious damageDiagnostic recording/measuringSensorsCreatinine riseClearance rate
The invention discloses an early warning system for a chronic renal failure, and belongs to the field of medical detection. The early warning system for the chronic renal failure comprises a data acquisition unit used for collecting the urine volume, urine creatinine and serum creatinine of a patient to generate detection values, a calculation unit used for calculating creatinine clearance rates according to the detection values, a prediction unit used for establishing a Markov-grey model, and calculating predicted values of the creatinine clearance rates in future time periods according to the N creatinine clearance rates calculated through the detection values of N detection time periods, wherein N is an integer greater than 3, and an early warning decision unit used for determining the early warning level of the chronic renal failure according to the predicted values of the creatinine clearance rates. According to the invention, modeling analysis is carried out on the creatinine clearance rates to predict the probability that a kidney has the chronic renal failure and timely discover non-overt renal injuries in early kidney asymptomatic lesions so as to provide effective help in clinical early confirmed diagnosis and later treatment.
Owner:CHONGQING TECH & BUSINESS UNIV
Chinese medicament for treating chronic kidney failure
The invention relates to a Chinese medicament for treating chronic kidney failure, and belongs to the field of Chinese medicaments for treating urinary system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: anemarrhena asphodeloides bunge, lucid ganoderma, common curculigo rhizome, prepared rhubarb, root of rehmannia, Chinese angelica, epimedium herb, radix pseudo-ginseng, oyster and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and tonifying and warming kidney Yang, and has the advantages of obvious effect, exact medicinal effect and quick response.
Owner:高金行
Pharmaceutical composition for treating chronic heart failure
The invention relates to a pharmaceutical composition comprising an angiotensin converting enzyme inhibitor (ACEI), an enkephalinase inhibitor, a folic acid compound and a pharmaceutically acceptable carrier, wherein the ACEI is selected from the group consisting of enalapril, benazepril, ramipril, fosinopril, cilazapril, perindopril and the like, and the content is 1.25-75 mg; the enkephalinase inhibitor is sacubitril, and the content is 10-120 mg; and the folic acid compound is selected from the group consisting of folic acid, 5-methyltetrahydrofolate, calcium formyltetrahydrofolate, leucovorin, calcium levofolinate and the like, and the content is 0.1-5 mg. The invention provides the use of the pharmaceutical composition in the preparation of a medicament for the treatment of chronic heart failure and the prevention of stroke. By the implementation of the invention, the pharmaceutical composition can also improve the compliance of patients and improve the therapeutic effect by providing the pharmaceutical composition for a specific use to the patients.
Owner:SHENZHEN AUSA PHARM CO LTD +1
Diagnostic and treatment of chronic heart failure
InactiveUS20150368715A1Extended half-lifeImprove stabilityMicrobiological testing/measurementDisease diagnosisPhysical therapyGene expression
Owner:INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)
Chinese medicine for treating chronic kidney failure
InactiveCN101028421ADefinite curative effectNo side effectsPowder deliveryAnthropod material medical ingredientsChronic kidney failureEpimedium
A Chinese medicine for treating chronic renal failure is prepared from more than 10 Chinese- medicinal materials including astragalus root, notoginseng, epimedium, ground beetle, etc.
Owner:北京金匮中医研究院有限公司
Medicament for treating chronic renal failure
The invention relates to a Chinese medicinal composition, and discloses a medicament for treating chronic renal failure. In the medicament, prepared rhubarb is used as a monarch medicament for removing heat and dampness and eliminating turbidity; glabrous greenbrier rhizome and paniculate swallowwort root are used as ministerial medicaments for detoxifying and removing dampness through diuresis; cowherb seed is used as an adjuvant medicament for activating blood circulation to dissipate blood stasis; and dried orange peel and pinellia tuber are used as conductant medicaments for harmonizing stomach and resolving dampness. The Chinese medicinal composition has therapeutic effect on chronic renal function failure, azotemia, and early-stage and medium-stage uremia, which are characterized by vital qi weakness, visceral function failure and dampness, turbidity, blood stasis and toxicosis in Chinese medicine, and is low in cost.
Owner:叶景华
Traditional Chinese medicine capable of delaying chronic renal failure
The invention provides a traditional Chinese medicine capable of delaying chronic renal failure, belongs to the technical field of traditional Chinese medicines, and solves the problem of absence of the traditional Chinese medicine for treating the chronic renal failure called in western medical science in the prior art. The traditional Chinese medicine is characterized by being prepared from components as follows: 15-25 g of membranous milkvetch roots, 2-5 g of cinnamon, 9-15 g of sevenlobed yam rhizomes, 15-25 g of Chinese yam rhizomes, 10-15 g of eucommia ulmoides, 10-25 g of motherwort herbs, 6-15 g of twotoothed achyranthes roots, 5-15 g of Chinese rhubarb, 9-15 g of glabrous greenbrier rhizomes and 3-10 g of liquorice roots; the astragalus membranaceus, the cortex cinnamomi, the Chinese yam rhizomes and the Chinese rhubarb are taken and smashed into fine powder, the fine powder is sieved and mixed uniformly, and mixed powder is obtained; the other components are decocted 3-5 times with water, the time consumed for the first decoction is 2-3 h, the time consumed for each time of later decoction is 0.5-1.5 h, detected liquids are combined and filtered, filtrate is obtained and concentrated, and thick pasty filtrate is obtained; the mixed powder is added to the thick pasty filtrate and mixed uniformly, a mixture is dried and smashed into fine powder, the fine powder is encapsulated, and the traditional Chinese medicine is obtained. The traditional Chinese medicine is used for treating the chronic renal failure.
Owner:JILIN ACAD OF TRADITIONAL CHINESE MEDICINE
Traditional Chinese medicine composition for treating chronic renal failure and application of traditional Chinese medicine composition for treating chronic renal failure
InactiveCN105998963ASignificant improvementNo side effectsPteridophyta/filicophyta medical ingredientsUrinary disorderHerba Scutellariae BarbataeChronic failure
The invention discloses a traditional Chinese medicine composition for treating chronic renal failure. The traditional Chinese medicine composition for treating chronic renal failure is prepared from, by weight, 3-8 parts of Folium Perillae, 5-12 parts of Fructus Mume, 12-17 parts of Folium Ginkgo, 4-6 parts of Semen Cuscutae, 8-12 parts of Radix Saposhnikoviae, 3-4 parts of Radix Sacchari Arundinacei, 12-15 parts of Fructus Rosae Multiflorae, 5-9 parts of Radix Cynanchi Paniculati, 3-4 parts of Herba Ziziphorae Clinopodioidis, 5-8 parts of Spica Prunellae, 12-15 parts of Radix Polygoni Multiflori, 10-16 parts of Radix Stellariae Yunnanensis, 7-12 parts of Herba Taraxaci, 4-9 parts of Herba Scutellariae Barbatae, 15-20 parts of Rhizoma Curculiginis, 10-15 parts of Herba Hedyotidis Diffusae, 8-12 parts of Radix Rubiae, 2-5 parts of Fructus Akebiae Quinatae, 3-7 parts of Herba Centellae, 11-14 parts of Flos Lonicerae, 9-15 parts of Radix Notoginseng, 3-6 parts of Herba Cistanche, 8-13 parts of Flos Campsis, 3-5 parts of Rhizoma Sparganii, 1-3 parts of Fructus Gardeniae, 5-10 parts of Herba Aleuritopteris Argentea, 5-10 parts of Medulla Junci, 13-16 parts of Herba Leonuri, 3-10 parts of Radix et Rhizoma Iridis Sanguineae and 8-13 parts of Rhizoma Pinelliae.
Owner:李永伟
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com